People withhypertrophic cardiomyopathy(HCM) have a greater risk of becoming severely ill from COVID-19.
It is both a major risk factor and a serious complication ofCOVID-19.
There are many types and causesof cardiomyopathy, and it can affect people of all ages.
fizkes / Getty Images
As cardiomyopathy worsens, the heart is less able to maintain a normalelectrical rhythm, resulting inheart failureand arrhythmia.
This is due to the bodyespecially the heartbecoming weaker by COVID-19.
Many tissues can rehabilitate themselves after illness, but heart tissue does not.
Once your heart muscle is damaged, its ability to function is permanently lowered.
Hypertrophic Cardiomyopathy Complications
Studies show there are serious complications associated with COVID-19 infection in people with HCM.
They are at a higher risk of heart complications, needing hospitalization, and dying.
Before the pandemic, about 1% to 2% ofacute coronary syndromecases were attributed to stress-induced cardiomyopathy.
During the pandemic, this number rose to about 8%.
These medications need to be started within days of initial symptoms.
Antiviral medications work by stopping parts of the COVID-19 virus from multiplying in the body.
Do not stop or change the dosage of your heart medications without consulting your healthcare provider first.
For instance, certain decongestants or cold medicines can change your heart rhythm.
Implantablepacemakersordefibrillatorsalso may be recommended to help the heart function better.
Call 911 immediately if you are in immediate danger.
If you are experiencing any kind of acute illness or distress, seek medical care right away.
The American Heart Association supports the COVID-19vaccinationfor people with a variety of heart conditions, including cardiomyopathy.
The information in this article is current as of the date listed.
As new research becomes available, well update this article.
For the latest on COVID-19, visit ourcoronavirus news page.
2021;97(1145):175-179. doi:10.1136/postgradmedj-2020-138080
MedlinePlus.Hypertrophic cardiomyopathy.
National Heart, Lung, and Blood Institute.What is cardiomyopathy?
2022;9(1):e001918.
Birnie DH, Healey JS, Essebag V.Management of anticoagulation around pacemaker and defibrillator surgery.Circulation.
2014;129(20):2062-5. doi:10.1161/CIRCULATIONAHA.113.006027
